DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lamotrigine (Lamotrigine) - Atrial Septal Defect - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Atrial Septal Defect (75)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Lamotrigine where reactions include atrial septal defect. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 75   Next >>

Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-24

Patient: female, weighing 3.5 kg (7.7 pounds)

Reactions: Atrial Septal Defect, Dysmorphism, Neonatal Respiratory Distress Syndrome, Maternal Exposure During Pregnancy, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folic Acid



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-24

Patient: female, weighing 3.5 kg (7.7 pounds)

Reactions: Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Dysmorphism, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Folic Acid
    Dosage: 5 mg, daily
    Indication: Prophylaxis of Neural Tube Defect

Lamotrigine
    Dosage: 500 mg/daily; 275 mg/daily during 1st trimester
    Indication: Epilepsy
    End date: 2011-02-12



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-24

Patient: female, weighing 3.5 kg (7.7 pounds)

Reactions: Atrial Septal Defect, Dysmorphism, Neonatal Respiratory Distress Syndrome, Maternal Exposure During Pregnancy, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folic Acid



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-07-23

Patient: female, weighing 3.5 kg (7.7 pounds)

Reactions: Atrial Septal Defect, Movement Disorder, Retrognathia, Maternal Drugs Affecting Foetus, Neonatal Respiratory Distress Syndrome, Dysmorphism, Congenital Hand Malformation, Cyanosis Neonatal, Limb Malformation, Bradycardia Neonatal, Congenital Pyelocaliectasis, Congenital Eyelid Malformation, Talipes, Pelvi-Ureteric Obstruction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folsaure (Folic Acid)



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-07-18

Patient: female

Reactions: Atrial Septal Defect, Dysmorphism, Neonatal Respiratory Distress Syndrome, Bradycardia Neonatal, Cyanosis, Respiratory Arrest, Talipes, Congenital Ureteric Anomaly

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folic Acid



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-07-18

Patient: female

Reactions: Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Dysmorphism, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folsaure



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-13

Patient: female, weighing 3.5 kg (7.7 pounds)

Reactions: Movement Disorder, Retrognathia, Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Maternal Drugs Affecting Foetus, Dysmorphism, Ultrasound Scan Abnormal, Cyanosis Neonatal, Bradycardia Neonatal, Congenital Eyelid Malformation, Congenital Anomaly, Talipes, Pyelocaliectasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 275 mg, during first trimester, transplacental; 500 mg, precon and throughout pregnancy, transplacen
    Indication: Product Used FOR Unknown Indication
    End date: 2011-02-12

Lamotrigine
    Dosage: 275 mg, during first trimester, transplacental; 500 mg, precon and throughout pregnancy, transplacen
    Indication: Product Used FOR Unknown Indication
    End date: 2011-02-12

Other drugs received by patient: Folsaure (Folic Acid)



Possible Lamotrigine side effects in

Reported by a physician from Germany on 2012-07-11

Patient:

Reactions: Atrial Septal Defect, Neonatal Respiratory Distress Syndrome, Dysmorphism, Talipes, Congenital Ureteric Anomaly, Bradycardia Neonatal

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folic Acid



Possible Lamotrigine side effects in

Reported by a individual with unspecified qualification from Germany on 2012-07-05

Patient: , weighing 3.2 kg (7.2 pounds)

Reactions: Atrial Septal Defect, Caesarean Section, Maternal Drugs Affecting Foetus, Ventricular Septal Defect, Cephalo-Pelvic Disproportion

Drug(s) suspected as cause:
Clonazepam
    Dosage: 0.5 mg, unk, transplacental
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Lamotrigine
    Dosage: 75 mg, unk, transplacental
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium (Thyroxin)



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-03

Patient: female, weighing 3.5 kg (7.7 pounds)

Reactions: Atrial Septal Defect, Retrognathia, Neonatal Respiratory Distress Syndrome, Maternal Drugs Affecting Foetus, Dysmorphism, Premature Baby, Cyanosis Neonatal, Bradycardia Neonatal, Eyelid Disorder, Talipes, Congenital Ureteric Anomaly, Pelvi-Ureteric Obstruction, Pyelocaliectasis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folic Acid (Folsaure)



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27

Patient: female, weighing 3.2 kg (7.2 pounds)

Reactions: Atrial Septal Defect, Maternal Exposure During Pregnancy, Ventricular Septal Defect

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 0.5 [mg/d ]
    Start date: 2011-04-14
    End date: 2012-01-06

Clonazepam
    Dosage: 75 [mg/d ]
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27

Patient: female, weighing 3.2 kg (7.2 pounds)

Reactions: Atrial Septal Defect, Maternal Exposure During Pregnancy, Ventricular Septal Defect

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 0.5 [mg/d ]
    Start date: 2011-04-14
    End date: 2012-01-06

Clonazepam
    Dosage: 75 [mg/d ]
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-27

Patient: female, weighing 3.2 kg (7.2 pounds)

Reactions: Atrial Septal Defect, Ventricular Septal Defect

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 75 [mg/d ]
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Clonazepam
    Dosage: 0.5 [mg/d]
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-26

Patient: female, weighing 3.3 kg (7.3 pounds)

Reactions: Atrial Septal Defect, Foetal Exposure During Pregnancy, Ventricular Septal Defect, Cephalo-Pelvic Disproportion

Drug(s) suspected as cause:
Clonazepam
    Dosage: .5mg per day
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Lamotrigine
    Dosage: 75mg per day
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-06-26

Patient: female

Reactions: Atrial Septal Defect, Ventricular Septal Defect

Drug(s) suspected as cause:
Clonazepam

Lamotrigine

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-06-21

Patient: female, weighing 3.2 kg (7.2 pounds)

Reactions: Atrial Septal Defect, Caesarean Section, Maternal Drugs Affecting Foetus, Ventricular Septal Defect, Cephalo-Pelvic Disproportion

Drug(s) suspected as cause:
Clonazepam
    Dosage: (0.5 mg, 1 d), transplacental
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Lamotrigine
    Dosage: (75 mg, 1 d), transplacental
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-18

Patient: female, weighing 3.2 kg (7.2 pounds)

Reactions: Atrial Septal Defect, Caesarean Section, Maternal Drugs Affecting Foetus, Congenital Anomaly, Ventricular Septal Defect, Cephalo-Pelvic Disproportion

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 75 mg, 1 in 1 d, transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-14
    End date: 2012-01-06

Clonazepam
    Dosage: 0.5 mg, 1 in 1 d, transplacental
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in 26 year old female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-18

Patient: 26 year old female

Reactions: Atrial Septal Defect, Caesarean Section, Ventricular Septal Defect, Cephalo-Pelvic Disproportion

Drug(s) suspected as cause:
Clonazepam
    Dosage: 0.5 mg, 1 in 1 d, oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Lamotrigine
    Dosage: 75 mg, 1 in 1 d, oral
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2011-04-14
    End date: 2012-01-06

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-14

Patient:

Reactions: Atrial Septal Defect, Foetal Exposure During Pregnancy, Ventricular Septal Defect

Drug(s) suspected as cause:
Lamotrigine
    Dosage: maternal dose: 75 mg/d until 38.1 gw

Antelepsin
    Dosage: maternal dose: 0.5 mg/d until 38.1 gw

Other drugs received by patient: Levothyroxine Sodium



Possible Lamotrigine side effects in

Reported by a physician from United Kingdom on 2012-06-13

Patient:

Reactions: Atrial Septal Defect, Dysmorphism, Foetal Exposure During Pregnancy, Patent Ductus Arteriosus

Drug(s) suspected as cause:
Levetiracetam

Lamotrigine

Valproate Sodium



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-06-04

Patient: female, weighing 2.8 kg (6.1 pounds)

Reactions: Atrial Septal Defect, Small FOR Dates Baby, Ventricular Septal Defect, Congenital Cystic Kidney Disease, Congenital Arterial Malformation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Clobazam
    Start date: 2011-07-18

Carbamazepine
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-06-08
    End date: 2011-10-13

Lamotrigine
    Start date: 2011-03-29

Topiramate
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-01-11
    End date: 2011-10-13

Valproic Acid
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-01-11
    End date: 2011-03-29

Levothyroxine Sodium
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-01-11
    End date: 2011-10-13

Lamotrigine
    Indication: Foetal Exposure During Pregnancy
    End date: 2011-05-25

Clobazam
    Indication: Foetal Exposure During Pregnancy
    End date: 2011-10-13

Clobazam
    Start date: 2011-03-29

Folic Acid
    Indication: Foetal Exposure During Pregnancy
    Start date: 2011-03-29
    End date: 2011-06-07



Possible Lamotrigine side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17

Patient:

Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus

Drug(s) suspected as cause:
Carbamazepine
    Dosage: transplacentary
    Indication: Epilepsy

Lamotrigine
    Dosage: 400 mg/transplacentary
    Indication: Epilepsy



Possible Lamotrigine side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-17

Patient:

Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Syndactyly, Patent Ductus Arteriosus, Congenital Anomaly, Meningomyelocele

Drug(s) suspected as cause:
Valproic Acid
    Dosage: 3000 mg / transplacentary
    Indication: Epilepsy

Lamotrigine
    Dosage: 100 mg/ transplacentary
    Indication: Epilepsy



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-02

Patient: female, weighing 3.4 kg (7.5 pounds)

Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Maternal Drugs Affecting Foetus

Drug(s) suspected as cause:
Lamotrigine



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-01

Patient: female, weighing 3.4 kg (7.5 pounds)

Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Lamotrigine



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-05-01

Patient: female, weighing 3.4 kg (7.5 pounds)

Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Maternal Exposure During Pregnancy

Drug(s) suspected as cause:
Lamotrigine



Possible Lamotrigine side effects in female

Reported by a physician from Germany on 2012-04-30

Patient: female, weighing 3.4 kg (7.5 pounds)

Reactions: Atrial Septal Defect, Bicuspid Aortic Valve, Foetal Exposure During Pregnancy

Drug(s) suspected as cause:
Lamotrigine



Possible Lamotrigine side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-24

Patient: female, weighing 3.4 kg (7.5 pounds)

Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Bicuspid Aortic Valve, Congenital Anomaly

Drug(s) suspected as cause:
Lamotrigine



Possible Lamotrigine side effects in male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-04-03

Patient: male, weighing 3.6 kg (7.9 pounds)

Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Hyperbilirubinaemia, Bradycardia Neonatal

Drug(s) suspected as cause:
Lamotrigine
    Dosage: 700 mg/d (225-225-250) for two years, transplacental
    Indication: Epilepsy
    Start date: 2009-11-11
    End date: 2010-08-11

Vimpat
    Dosage: 200 mg/d (100-0-100) for one year (unknown), transplacental
    Indication: Epilepsy
    Start date: 2009-11-11
    End date: 2010-08-11

Other drugs received by patient: Folic Acid (Folsaure)



Possible Lamotrigine side effects in male

Reported by a consumer/non-health professional from Germany on 2012-04-03

Patient: male, weighing 3.3 kg (7.3 pounds)

Reactions: Atrial Septal Defect, Maternal Drugs Affecting Foetus, Caesarean Section, Ventricular Septal Defect

Drug(s) suspected as cause:
Lamotrigine

Other drugs received by patient: Folic Acid (Folsan)



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017